Double-blind Placebo-controlled Trial on the Effects of Statin prior to Percutaneous Coronary Interventions studied in Japanese subjects
Not Applicable
- Conditions
- Patients with Ischemic Heart Disease who will undergo PCI
- Registration Number
- JPRN-UMIN000000576
- Lead Sponsor
- Department of Cardiovascular Medicine Kyushu University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Cases that requires emergent revascularization such as STEMI. Cases with grave complications such as pulmonary edema or cardiogenic shock. Cases with severe hyperlipidemia such as familial hypercholesterolemia who should be treated with statin. High risk cases for rhabdomyolysis such as hypothyroidism or taking fibrates. Pregnant or nursing female cases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method